Acute Appendicitis
Neurology·MeSH: Appendicitis
Prevalence
11.7 / 100K
Incidence
307.3 / 100K/yr
3 drugs in development·2 companies·2 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| IV tramadol | AVENUE THERAPEUTICS, INC. (ATXI) |
Unknown(2)
Compare drugs
Frequently asked questions
How many drugs are in development for Acute Appendicitis?
BioSniper tracks 3 drugs in development for Acute Appendicitis across 2 companies.
How many clinical trials target Acute Appendicitis?
There are 2 clinical trials targeting Acute Appendicitis tracked by BioSniper.
What is the prevalence of Acute Appendicitis?
The estimated prevalence of Acute Appendicitis is approximately 11.7 per 100,000 population.
Deep-dive into Acute Appendicitis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis